Company Filing History:
Years Active: 2018
Title: **Innovative Approaches in Hematocrit Measurement: The Work of Shu-Wei Yang**
Introduction
Shu-Wei Yang, an innovative inventor based in Zhongli, Taiwan, has made significant contributions to the field of healthcare technology. With a unique approach to measuring hematocrit levels, his work reflects a commitment to enhancing diagnostic processes through advanced methodologies.
Latest Patents
Shu-Wei Yang holds a patent titled "Method of Measuring Hematocrit (HCT), and Measurement Device Using the Method." This invention introduces a method for measuring hematocrit levels in blood through an electrode test specimen. The technique involves creating a capacitor charging effect, which leads to a consequential change in discharge current, thereby allowing precise measurement of hematocrit. The process comprises several steps: first, blood is instilled into a pair of test electrodes equipped in the device and a voltage is applied; second, the voltage is removed to measure the discharge current value; finally, by referencing a predetermined decision rule, the hematocrit value is obtained. This innovative approach offers enhanced precision and reliability compared to traditional hematocrit testing methods.
Career Highlights
Shu-Wei Yang currently works at Broadmaster Biotech Corp, a company that specializes in developing advanced biotechnological solutions. His career is marked by a dedication to research and innovation, particularly in the domain of blood analysis, showcasing his ingenuity and expertise.
Collaborations
At Broadmaster Biotech Corp, Shu-Wei collaborates with notable coworkers Yi-Lung Chen and Chien-Hung Lai. Together, they contribute to pioneering projects that strive to elevate the standards of medical diagnostics through innovative technologies.
Conclusion
Shu-Wei Yang's contributions to hematocrit measurement technology exemplify the critical role of innovation in healthcare. His patented method not only enhances the precision of hematocrit testing but also reflects a broader trend toward improving diagnostic tools. As he continues his work at Broadmaster Biotech Corp, the impact of his inventions will likely be felt across the medical field, ensuring better health outcomes for patients.